| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Former 10% Owner
4 companies
Abingworth LLP last filed a Form 4 in March 2022, as 10% Owner at SLNO. The filings on record cover 4 companies. Abingworth LLP's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 2,960,231 shares of VERA. Net of sales, the VERA filings show accumulation of 772,727 shares.
Abingworth LLP has 18 Form 4 filings on record from June 2015 to March 2022, across 6 companies: 10% Owner at Jasper Therapeutics (JSPR), 2022; 10% Owner at Vera Therapeutics (VERA), 2021; Former 10% Owner at Personalis (PSNL), 2019–2020, and 3 more.
The 31 reported transactions were 11 option or other derivative awards, 8 open-market sales, 6 open-market purchases and 5 conversions, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 3 purchases worth about $16.8M and 5 sales worth about $38.5M.
The largest open-market purchase was 772,727 shares of VERA at an average $11.00 on May 18, 2021, about $8.5M. Twelve months later VERA was up 33%.
The largest open-market sale was 986,842 shares of PSNL at an average $19.00 on August 18, 2020, about $18.7M.
Shares as reported in the last Form 4 for each company; the most recent is from March 2022. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 29, 2022 | SLNO Soleno Therapeutics Inc | 10% Owner | Buy | 7,720,000 | $0.00 | - | +74.9% | -19.7% | -31.2% | |
| May 18, 2021 | VERA Vera Therapeutics, Inc. | 10% Owner | Buy | 772,727 | $11.00 | $8,499,997.00 | +35.3% | +37.7% | +32.9% | |
| Oct 20, 2020 | PSNL Personalis, Inc. | Former 10% Owner | Sell | 130,486 | $27.66 | $3,609,242.76 | -3.4% | - | - | |
| Oct 19, 2020 | PSNL Personalis, Inc. | 10% Owner | Sell | 290,641 | $27.48 | $7,986,081.02 | -7.0% | - | - | |
| Oct 15, 2020 | PSNL Personalis, Inc. | 10% Owner | Sell | 85,625 | $27.05 | $2,315,913.00 | -2.0% | - | - | |
| Oct 13, 2020 | PSNL Personalis, Inc. | 10% Owner | Sell | 202,360 | $28.81 | $5,829,351.86 | -4.5% | - | - | |
| Aug 18, 2020 | PSNL Personalis, Inc. | 10% Owner | Sell | 986,842 | $19.00 | $18,749,998.00 | -18.1% | - | - | |
| Jun 26, 2020 | SLNO Soleno Therapeutics Inc | 10% Owner | Buy | 3,333,330 | $1.65 | $5,499,994.50 | +47.8% | - | - | |
| Oct 25, 2019 | SLNO Soleno Therapeutics Inc | 10% Owner | Buy | 2,300,000 | $1.20 | $2,760,000.00 | +49.3% | - | - |